Increased TGF-β signaling during antiestrogen therapy in triple-negative breast cancer cells
The Journal of Steroid Biochemistry and Molecular Biology · 2026
DOI: 10.1016/j.jsbmb.2025.106934 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Steroid Biochemistry and Molecular Biology, 2026. Verfasst von Nandani Dharwal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Science, Nirma University, Ahmedabad, Gujarat 382481, India. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Tamoxifen, Signal Transduction, Transforming Growth Factor beta1. Die Arbeit nennt 47 Literaturangaben. Gefördert von: Nirma University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Science, Nirma University, Ahmedabad, Gujarat 382481, India.
- Institute of Science, Nirma University, Ahmedabad, Gujarat 382481, India. Electronic address: heena.dave@nirmauni.ac.in.
Förderung
- Nirma University
Zitieren
APA
Dharwal, N., Rathore, D., Shukla, N., & Dave, H. V. (2026). Increased TGF-β signaling during antiestrogen therapy in triple-negative breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. https://doi.org/10.1016/j.jsbmb.2025.106934
Vancouver
Dharwal N, Rathore D, Shukla N, Dave HV. Increased TGF-β signaling during antiestrogen therapy in triple-negative breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 2026. doi:10.1016/j.jsbmb.2025.106934
BibTeX
@article{Dharwal2026,
author = {Dharwal, Nandani and Rathore, Deepshikha and Shukla, Nirali and Dave, Heena V},
title = {Increased TGF-β signaling during antiestrogen therapy in triple-negative breast cancer cells},
journal = {The Journal of Steroid Biochemistry and Molecular Biology},
year = {2026},
doi = {10.1016/j.jsbmb.2025.106934}
}
EUVIMED